![]()
34
| 2 | 2008
Klinisk Biokemi i Norden
(Fortsat fra side 33)
Referencer
1. Sudoh T, Minamino N, Kangawa K, Matsuo
H. C-type natriuretic peptide (CNP): a new
member of natriuretic peptide family identi-
fied in porcine brain. Biochem Biophys Res
Commun 1990;168:863-70.
2. Casco VH, Veinot JP, Kuroski de Bold ML,
Masters RG, Stevenson MM, de Bold AJ.
Natriuretic peptide system gene expression
in human coronary arteries. J Histochem
Cytochem 2002;50:799-809.
3. Heublein DM, Clavell AL, Stingo AJ, Lerman
A, Wold L, Burnett JC, Jr. C-type natriu-
retic peptide immunoreactivity in human
breast vascular endothelial cells. Peptides
1992;13:1017-9.
4. Kelsall CJ, Chester AH, Sarathchandra P,
Singer DR. Expression and localization of
C-type natriuretic peptide in human vascular
smooth muscle cells. Vascul Pharmacol 2006.
5. Chusho H, Tamura N, Ogawa Y, Yasoda A,
Suda M, Miyazawa T et al. Dwarfism and
early death in mice lacking C-type natriu-
retic peptide. Proc Natl Acad Sci U S A
2001;98:4016-21.
6. Prickett TC, Lynn AM, Barrell GK, Darlow
BA, Cameron VA, Espiner EA et al. Amino-
terminal proCNP: a putative marker of carti-
lage activity in postnatal growth. Pediatr Res
2005;58:334-40.
7. Yasoda A, Komatsu Y, Chusho H, Miyazawa
T, Ozasa A, Miura M et al. Overexpression of
CNP in chondrocytes rescues achondroplasia
through a MAPK-dependent pathway. Nat
Med 2004;10:80-6.
8. Chrisman TD, Schulz S, Potter LR, Garbers
DL. Seminal plasma factors that cause
large elevations in cellular cyclic GMP are
C-type natriuretic peptides. J Biol Chem
1993;268:3698-703.
(Fortsætter side 32)
Foto: Søren Junge Nielsen. New Zealand.
